Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora

Article Abstract:

Radioisotope experiments are performed to study the pathways of short-chain fatty acid formation from glucose and carbohydrates for the human colonic ecosystem. Results show that the major route of glucose catabolism for human fecal microbial flora is the Embden-Meyerhof-Parnas pathway while acetate id formed from CO2 by the Wood-Ljungdahl pathway. The data also suggest that the Entner-Doudoroff, transketolase-transaldolsae and heterolactic pathways are not significant in this process.

Author: Wolin, Meyer J., Miller, Terry L.
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 1996
Fatty acids, Microbial populations, Fatty acid synthesis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon

Article Abstract:

A study has revealed the potential application of acarbose as an agent of change in colonic fermentation pathways. Acarbose is an oligosaccharide that is also an alpha-glucosidase inhibitor used in the treatment of non-insulin dependent diabetes. It has been observed that inhibition of starch digestion in human intestines increases the starch availability for microbial fermentation into acetate, propionate and butyrate in the human colon.

Author: Wolin, Meyer J., Miller, Terry L., Yerry, Susan, Zhang, Yongchao, Bank, Shelton, Weaver, Gary A.
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 1999
Antitoxins, Colon (Anatomy), Colon, Acarbose

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Amounts of viable anaerobes, methanogens, and bacterial fermentation products in feces of rats fed high fiber or fiber-free diets

Article Abstract:

The effect of a fiber diet on the production of fecal microorganisms and microbial fermentation products of rats was studied. Male wistar rats were fed with high-fiber and fiber-free diets. High-performance liquid chromatography was used to characterize the production of soluble fermentations. Microbial growth in the colon was significantly increased by high-fiber diets as it also affects the ratio of organic acid production.

Author: Maczulak, Anne E., Wolin, Meyer J., Miller, Terry L.
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 1993
Rats, Animal nutrition, Dietary fiber, Fiber in animal nutrition

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Analysis, Feces, Microbiology, Research
Similar abstracts:
  • Abstracts: Effects of hydrogen and formate on the degradation of propionate and butyrate in thermophilic granules from an upflow anaerobic sludge blanket reactor
  • Abstracts: Metabolism of benzonitrile and butyronitrile by Klebsiella pneumoniae. Anaerobic metabolism of 1-amino-2-naphthol-based azo dyes (Sudan dyes) by human intestinal microflora
  • Abstracts: Degradation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans by the white rot fungus Phanerochaete sordida YK-624
  • Abstracts: Relationship between succinate transport and production of extracellular poly(3-hydroxybutyrate) depolymerase in Pseudomonas lemoignei
  • Abstracts: High-pressure-mediated survival of Clostridium botulinum and Bacillus amyloliquefaciens endospores at high temperature
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.